Abstract:Jumonji-domain-containing protein 6 (JMJD6) is a Fe(II) and 2-oxogluterate (2OG) dependent oxygenase involved in gene regulation through post-translationally modifying nuclear proteins. It is highly expressed in many cancer types and linked to tumor progression and metastasis. Four alternatively-spliced jmjd6 transcripts were annotated. Here, we focus on the two most abundantly expressed ones, which we call jmjd6-2 and jmjd6-Ex5. TCGA SpliceSeq data revealed a significant decrease of jmjd6-Ex5 transcripts in patients and postmortem tissue of several tumors. The two protein isoforms are distinguished by their C-terminal sequences, which include a serine-rich region (polyS-domain) in JMJD6-2 that is not present in JMJD6-Ex5. Immunoprecipitation followed by LC-MS/MS for JMJD6-Ex5 shows that different sets of proteins interact with JMJD6-2 and JMJD6-Ex5 with only a few overlaps. In particular, we found TFIIF-associating CTD phosphatase (FCP1), proteins of the survival of motor neurons (SMN) complex, heterogeneous nuclear ribonucleoproteins (hnRNPs) and upstream binding factor (UBF) to interact with JMJD6-Ex5. Like JMJD6-2, both UBF and FCP1 comprise a polyS-domain. The polyS domain of JMJD6-2 might block the interaction with polyS-domains of other proteins. In contrast, JMJD6-2 interacts with many SR-like proteins with arginine/serine-rich (RS)-domains, including several splicing factors. In an HIV-based splicing reporter assay, co-expression of JMJD6-2 inhibited exon inclusion, whereas JMJD6-Ex5 did not have any effect. Furthermore, the silencing of jmjd6 by siRNAs favored jmjd6-Ex5 transcripts, suggesting that JMJD6 controls splicing of its own pre-mRNA. The distinct molecular properties of JMJD6-2 and JMJD6-Ex5 open a lead into the functional implications of the variations of their relative abundance in tumors.

JmjC Domain-containing Protein 6 (jmjd6) Derepresses the Transcriptional Repressor Transcription Factor 7-Like 1 (tcf7l1) and is Required for Body Axis Patterning During Xenopus Embryogenesis.

JMJD5 Interacts with P53 and Negatively Regulates P53 Function in Control of Cell Cycle and Proliferation.

Isoform- and dose-sensitive feedback interactions between paired box 6 gene and δ-catenin in cell differentiation and death

Jun Nh2-Terminal Kinase (Jnk) Prevents Nuclear Beta-Catenin Accumulation And Regulates Axis Formation In Xenopus Embryos

The Histone Demethylase Jmjd3 Regulates Zebrafish Myeloid Development by Promoting Spi1 Expression.

Repression through a distal TCF-3 binding site restricts Xenopus myf-5 expression in gastrula mesoderm.

Jun NH 2 -Terminal Kinase (JNK) Prevents Nuclear Β-Catenin Accumulation and Regulates Axis Formation in Xenopus Embryos

XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos

Smad6 Promotes Neuronal Differentiation In The Intermediate Zone Of The Dorsal Neural Tube By Inhibition Of The Wnt/Beta-Catenin Pathway

JMJD3 Facilitates C/EBPβ-centered Transcriptional Program to Exert Oncorepressor Activity in AML

Jumonji Modulates Polycomb Activity and Self-Renewal Versus Differentiation of Stem Cells

JMJD6 Regulates Splicing of Its Own Gene Resulting in Alternatively Spliced Isoforms with Different Nuclear Targets

JMJD1C Ensures Mouse Embryonic Stem Cell Self-Renewal and Somatic Cell Reprogramming Through Controlling MicroRNA Expression.

JMJD3 Acts in Tandem with KLF4 to Facilitate Reprogramming to Pluripotency.

Regulation of alphabeta/gammadelta T cell development by the activator protein 1 transcription factor c-Jun.

HMCES modulates the transcriptional regulation of nodal/activin and BMP signaling in mESCs

Modulation of brassinosteroid-regulated gene expression by jumonji domain-containing proteins ELF6 and REF6 in Arabidopsis

HMCES modulates the transcriptional regulation of nodal/activin and BMP signaling in mESCs.

Xenopus Tbx6 Mediates Posterior Patterning Via Activation of Wnt and FGF Signalling

Histone Demethylase Jmjd3 Controls T-Cell Trafficking and Persistence by Interacting with Klf2 for Expression of Pdlim4

Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response